EHJ - Cardiovascular Pharmacotherapy
Focusing on clinical cardiovascular pharmacology
Showing 24 of 862 results
ESC Journals
Treatment effects in contemporary cardiovascular pharmacotherapy: determinants and interpretation
14 July 2026
ESC Journals
Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?
29 May 2026
ESC Journals
ESC Journals
ESC Journals
Kidney function and acid–base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial
18 May 2026
ESC Journals
Correction to: Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus
18 May 2026
ESC Journals
Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study
15 May 2026
ESC Journals
Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study
7 May 2026
ESC Journals
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with drug coated balloons in acute coronary syndromes: insights from the SWEDEHEART registry
7 May 2026
ESC Journals
Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: win ratio analysis of ADVANCE trial
29 April 2026
ESC Journals
Initiation of eplerenone vs. spironolactone and all-cause mortality in HFrEF: linked database study
28 April 2026
ESC Journals
Implementation of novel antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study
27 April 2026
ESC Journals
ESC Journals
Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects
24 April 2026
ESC Journals
Monoclonal antibodies targeting IL-5/5R or IL-4/13 pathways in eosinophilic myocarditis: a single-centre experience and systematic literature review
21 April 2026
ESC Journals
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions
11 April 2026
ESC Journals
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions
11 April 2026
ESC Journals
Implementing sodium–glucose co-transporter 2 inhibitors in cardiovascular–kidney–metabolic syndrome: a multidisciplinary expert perspective
10 April 2026
ESC Journals
ESC Journals
Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes Insights from SHEBAHEART big data registry
30 March 2026
ESC Journals
ESC Journals
Cardiotoxicity in dual immune checkpoint inhibitors: a critical appraisal of signal interpretation and future directions
19 March 2026
ESC Journals
Targeted anticoagulant reversal, unintended consequences: lessons from andexanet alfa
13 March 2026
ESC Journals
